Chiesi Group pays great attention to the safety of its products.
Following ethical principles and Russian legislation requirements, Chiesi Group collects and analyses information on adverse events, as well as maintains effective cooperation with regulatory authorities in this field.
Timely detection of adverse reactions and their reporting to Regulatory authorities allows for analysis and, based on its results, development and practical application of measures intended to prevention of adverse consequences of drug therapy, enhancing its safety and, therefore, patients’ quality of life.
In case of any adverse event that occurs while taking a medication of Chiesi Group, please send your notification by e-mail pharmacovigilance.ru@chiesi.com.
All the information you provide will be kept strictly confidential.
You can also contact by calling the number +7 495 967 12 12, +7 965 241 62 07 or 7 964-518-02-56.
